BVA-100

DEVICE3 trials

Sponsors

NYU Langone Health, Daxor Corporation

Conditions

Acute Decompensated Heart FailureAcute Respiratory Distress SyndromeBacterial InfectionsBacterial SepsisCovid19Heart Failure

Unknown Phase

Blood Volume Assessment in COVID-19 and Bacterial Sepsis

CompletedNCT04517695

NYU Langone HealthAcute Respiratory Distress Syndrome, Bacterial Infections, Bacterial Sepsis +1

Start: 2020-08-01End: 2023-04-09Updated: 2023-09-21

Monitoring Outpatient Blood VolumE in Heart Failure

CompletedNCT04660396

Daxor CorporationHeart Failure

Start: 2021-09-16End: 2022-07-30Updated: 2023-09-29

Evaluation of Blood Volume Analysis- Guided Management of Decompensated Heart Failure

CompletedNCT04855097

Daxor CorporationAcute Decompensated Heart Failure

Start: 2022-05-01End: 2022-12-31Updated: 2023-09-29

Related Papers

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method.

2021-03-16125 citations